Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Anticancer drug resistance: An update and perspective
Ruth Nussinov, Chung‐Jung Tsai, Hyunbum Jang
Drug Resistance Updates (2021) Vol. 59, pp. 100796-100796
Open Access | Times Cited: 246

Showing 51-75 of 246 citing articles:

Yi-qi-hua-yu-jie-du decoction induces ferroptosis in cisplatin-resistant gastric cancer via the AKT/GSK3β/NRF2/GPX4 axis
Wenjie Huang, Fang Wen, Peipei Yang, et al.
Phytomedicine (2023) Vol. 123, pp. 155220-155220
Closed Access | Times Cited: 19
Novel 7-Chloro-4-aminoquinoline-benzimidazole Hybrids as Inhibitors of Cancer Cells Growth: Synthesis, Antiproliferative Activity, in Silico ADME Predictions, and Docking
Luka Krstulović, Marijana Jukić, Vesna Rastija, et al.
Molecules (2023) Vol. 28, Iss. 2, pp. 540-540
Open Access | Times Cited: 16
Targeting EphA2: a promising strategy to overcome chemoresistance and drug resistance in cancer
Rafaela Nasser Veiga, Alexandre Luiz Korte de Azevedo, Jaqueline Carvalho de Oliveira, et al.
Journal of Molecular Medicine (2024) Vol. 102, Iss. 4, pp. 479-493
Closed Access | Times Cited: 7
Cuproptosis, the novel type of oxidation-induced cell death in thoracic cancers: can it enhance the success of immunotherapy?
Ruiwen Zhao, Olga Sukocheva, Edmund C. M. Tse, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 7
The value of protein allostery in rational anticancer drug design: an update
Ruth Nussinov, Hyunbum Jang
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 9, pp. 1071-1085
Open Access | Times Cited: 7
Overcoming Cancer Drug Resistance with Nanoparticle Strategies for Key Protein Inhibition
Hyeonji Yoo, Yeonjin Kim, Jinseong Kim, et al.
Molecules (2024) Vol. 29, Iss. 17, pp. 3994-3994
Open Access | Times Cited: 7
Research Progress of Long Non-Coding RNA in Tumor Drug Resistance: A New Paradigm
Jing Zhang, Le Wu, Chenchen Wang, et al.
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 1385-1398
Open Access | Times Cited: 6
ARID3A enhances chemoresistance of pancreatic cancer via inhibiting PTEN-induced ferroptosis
Xiaoqi Mao, Jin Xu, Mingming Xiao, et al.
Redox Biology (2024) Vol. 73, pp. 103200-103200
Open Access | Times Cited: 6
A protracted war against cancer drug resistance
Yuan Tian, Xiaowei Wang, Cong Wu, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 6
Nanomedicines for Overcoming Cancer Drug Resistance
Tingting Hu, Hanlin Gong, Jiayue Xu, et al.
Pharmaceutics (2022) Vol. 14, Iss. 8, pp. 1606-1606
Open Access | Times Cited: 27
A New View of Activating Mutations in Cancer
Ruth Nussinov, Chung‐Jung Tsai, Hyunbum Jang
Cancer Research (2022) Vol. 82, Iss. 22, pp. 4114-4123
Open Access | Times Cited: 25
Targeting Tumor Microenvironment by Metal Peroxide Nanoparticles in Cancer Therapy
Simon N. Mbugua
Bioinorganic Chemistry and Applications (2022) Vol. 2022, Iss. 1
Open Access | Times Cited: 25
Neurodevelopmental disorders, immunity, and cancer are connected
Ruth Nussinov, Chung‐Jung Tsai, Hyunbum Jang
iScience (2022) Vol. 25, Iss. 6, pp. 104492-104492
Open Access | Times Cited: 24
Precision Anti-Cancer Medicines by Oligonucleotide Therapeutics in Clinical Research Targeting Undruggable Proteins and Non-Coding RNAs
Damiano Bartolucci, Andrea Pession, Patrizia Hrelia, et al.
Pharmaceutics (2022) Vol. 14, Iss. 7, pp. 1453-1453
Open Access | Times Cited: 24
Therapeutic Implications of the Drug Resistance Conferred by Extracellular Vesicles Derived from Triple-Negative Breast Cancer Cells
Yong Weon Yi
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3704-3704
Open Access | Times Cited: 15
Strategy toward Kinase-Selective Drug Discovery
Mingzhen Zhang, Yonglan Liu, Hyunbum Jang, et al.
Journal of Chemical Theory and Computation (2023) Vol. 19, Iss. 5, pp. 1615-1628
Open Access | Times Cited: 15
The versatile roles of testrapanins in cancer from intracellular signaling to cell–cell communication: cell membrane proteins without ligands
Zhihang Zhou, Zihan Yang, Li Zhou, et al.
Cell & Bioscience (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 15
Bacterial Drug Delivery Systems for Cancer Therapy: “Why” and “How”
Xiangcheng Zhao, Nuli Xie, Hailong Zhang, et al.
Pharmaceutics (2023) Vol. 15, Iss. 9, pp. 2214-2214
Open Access | Times Cited: 15
NF1 alterations in cancers: therapeutic implications in precision medicine
Jean-Stéphane Giraud, Ivan Bièche, Éric Pasmant, et al.
Expert Opinion on Investigational Drugs (2023) Vol. 32, Iss. 10, pp. 941-957
Closed Access | Times Cited: 14
The role of HOTAIR in the modulation of resistance to anticancer therapy
Monica Cantile, Valentina Belli, Giosuè Scognamiglio, et al.
Frontiers in Molecular Biosciences (2024) Vol. 11
Open Access | Times Cited: 5
Single cell spatial biology over developmental time can decipher pediatric brain pathologies
Ruth Nussinov, Bengi Ruken Yavuz, Hyunbum Jang
Neurobiology of Disease (2024) Vol. 199, pp. 106597-106597
Open Access | Times Cited: 5
Screening Methods to Discover the FDA-Approved Cancer Drug Encorafenib as Optimally Selective for Metallothionein Gene Loss Ovarian Cancer
Amy Rees, Evan D. Villamor, Della Evans, et al.
Genes (2025) Vol. 16, Iss. 1, pp. 42-42
Open Access
Canonical and noncanonical NOTCH signaling in the nongenetic resistance of cancer: distinct and concerted control
Xianzhe Huang, Wenwei Chen, Yanyan Wang, et al.
Frontiers of Medicine (2025)
Closed Access
Golgi scaffold protein PAQR11 in pan-cancer landscape: a comprehensive bioinformatics exploration of expression patterns, prognostic significance, and potential immunological function
Zhu Liu, Zhi‐Qiang Ling
Heliyon (2025) Vol. 11, Iss. 2, pp. e41724-e41724
Closed Access
Synthesis and Biological Evaluation of a New Biphenyl-Based Organogold(III) Complex with In Vitro and In Vivo Anticancer Activity
Edwyn Remadna, Anna Wilsmann, Nicolas Städler, et al.
Journal of Medicinal Chemistry (2025)
Closed Access

Scroll to top